Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review

Abstract

Background Pharmacists’ counseling has improved health-related outcomes in many acute and chronic conditions. Several studies have shown how pharmacists have been contributing to reduce morbidity and mortality related to drug-therapy (MMRDT). However, there still is a lack of reviews that assemble evidence-based clinical pharmacists’ counseling. Equally, there is also a need to understand structure characteristics, processes and technical contents of these clinical services. Aim of the review To review the structure, processes and technical contents of pharmacist counseling or education reported in randomized controlled trials (RCT) that had positive health-related outcomes. Methods We performed a systematic search in specialized databases to identify RCT published between 1990 and 2013 that have evaluated pharmacists’ counseling or educational interventions to patients. Methodological quality of the trials was assessed using the Jadad scale. Pharmacists’ interventions with positive clinical outcomes (p < 0.05) were evaluated according to patients’ characteristics, setting and timing of intervention, reported written and verbal counseling. Results 753 studies were found and 101 RCT matched inclusion criteria. Most of the included RCTs showed a Jadad score between two (37 studies) and three (32 studies). Pharmacists were more likely to provide counseling at ambulatories (60 %) and hospital discharge (25 %); on the other hand pharmacists intervention were less likely to happen when dispensing a medication. Teaching back and explanations about the drug therapy purposes and precautions related to its use were often reported in RCT, whereas few studies used reminder charts, diaries, group or electronic counseling. Most of studies reported the provision of a printed material (letter, leaflet or medication record card), regarding accessible contents and cultural-concerned informations about drug therapy and disease. Conclusion Pharmacist counseling is an intervention directed to patients’ health-related needs that improve inter-professional and inter-institutional communication, by collaborating to integrate health services. In spite of reducing MMRDT, we found that pharmacists’ counseling reported in RCT should be better explored and described in details, hence collaborating to improve medication-counseling practice among other countries and settings.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    World Health Organization (WHO). International pharmaceutical federation (FIP). Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services. WHO technical report series. 2011; 961:1–14.

  2. 2.

    González-Martin G, Joo I, Sánchez I. Evaluation of the impact of a pharmaceutical care program in children with asthma. Patient Educ Couns. 2003:13–8.

  3. 3.

    Sarkadi A, Rosenqvist U. Experience-based group education in Type 2 diabetes: a randomised controlled trial. Patient Educ Couns. 2004:291–8.

  4. 4.

    Al-Saffar N, Abdulkareem A, Abdulhakeem A, Salah AQ, Heba M. Depressed patients’ preferences for education about medications by pharmacists in Kuwait. Patient Educ Couns. 2008;72:94–101.

    PubMed  Article  Google Scholar 

  5. 5.

    Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns. 2008;72:26–33.

    PubMed  Article  Google Scholar 

  6. 6.

    O’Connor J, Seeto C, Saini B, Bosnic-Anticevich S, Krass I, Armour C, Smith L. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Educ Couns. 2008:111–7.

  7. 7.

    Geurts MM, Pot JL, Schepers EH, Tromp C, Colijn CG, Dijkstra A, de Gier JJ. The evaluation of an intervention based on the application of patient self-completion concordance forms in Dutch community pharmacies and the effect on adherence to chronic medication. Patient Educ Couns. 2010;78:85–90.

    PubMed  Article  Google Scholar 

  8. 8.

    Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low-and middle-income countries. Cochrane Database of Systematic Reviews 2013.

  9. 9.

    Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions Version 5.1.0. The cochrane collaboration. 2011.

  10. 10.

    Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA group preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6(7).

  11. 11.

    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing quality of reports of randomized clinical trials: is blinding necessary? NY Control Clin Trials. 1996;17:1–12.

    Article  CAS  Google Scholar 

  12. 12.

    Razali SM, Yahya H. Health education and drug counseling for schizophrenia. Int Med J. 1997:187–9.

  13. 13.

    Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV, Kobak KA. Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. J Am Pharm Assoc. 2005;45:344–53.

    Article  Google Scholar 

  14. 14.

    Robinson JD, Segal R, Lopez LM, Doty RE. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Ann Pharmacother. 2010;44:88–96.

    PubMed  Article  Google Scholar 

  15. 15.

    Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, Dittus RS, Weinberger M, Pignone MP. A randomized trial of a primary care–based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med. 2005;118:9.

    Google Scholar 

  16. 16.

    Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT. Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications. Clin Transplant. 2001;15:330–6.

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Clifford RM, Batty KT, Davis WA, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes—The Fremantle diabetes study. Diabetes Care. 2005;28:771–6.

    PubMed  Article  Google Scholar 

  18. 18.

    Lee M, Kemp JA, Canning A, Egan C, Tataronis G, Farraye FA. A randomized controlled trial of an enhanced patient compliance program for helicobacter pylori therapy. Arch Intern Med. 1999;159:2312–6.

    PubMed  CAS  Google Scholar 

  19. 19.

    McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT. SCRIP-HTN Investigators. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008;168:2355–61.

    PubMed  Article  Google Scholar 

  20. 20.

    Sookaneknun P, Richards RM, Sanguansermsri J, Teerasut C. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother. 2004;38:2023–8.

    PubMed  Article  Google Scholar 

  21. 21.

    Stevens VJ, Shneidman RJ, Johnson RE, Boles M, Steele PE, Lee NL. Helicobacter pylori eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy intervention. West J Med. 2002;176:92–6.

    PubMed  PubMed Central  Google Scholar 

  22. 22.

    Gammaitoni AR, Gallagher RM, Welz M, Gracely EJ, Knowlton CH, Voltis-Thomas O. Palliative pharmaceutical care: a randomized, prospective study of telephone-based prescription and medication counseling services for treating chronic pain. Pain Med. 2000;1:317–31.

    PubMed  Article  CAS  Google Scholar 

  23. 23.

    Johnson KA, Parker JP, McCombs JS, Cody M. The Kaiser permanente/USC patient consultation study: patient satisfaction with pharmaceutical services. University of Southern California. Am J Health Syst Pharm. 1998:2621–9.

  24. 24.

    Tsuyuki RT, Fradette M, Johnson JA, Bungard TJ, Eurich DT, Ashton T, Gordon W, Ikuta R, Kornder J, Mackay E, Manyari D, O’Reilly K, Semchuk W. A multicenter disease management program for hospitalized patients with heart failure. J Card Fail. 2004;10:473–80.

    PubMed  Article  Google Scholar 

  25. 25.

    López Cabezas C, Falces Salvador C, Cubí Quadrada D, Arnau Bartés A, Ylla Boré M, Muro Perea N, Homs Peipoch E. Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure. Farm Hosp. 2006; 30(6):328-42.

  26. 26.

    Read H, Ladds S, Rhodes B, Brown D, Portlock J. The impact of a supplementary medication review and counseling service within the oncology outpatient setting. Br J Cancer. 2007;96:744–51.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  27. 27.

    Al-Asseri AA, Al-Achi A, Greenwood R. Counseling and post-discharge care. Saudi Pharm J. 2001:119–21.

  28. 28.

    Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counseling to elderly patients prior to discharge. Br J Clin Pharmacol. 2002;54:657–64.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  29. 29.

    Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001;96:325–31.

    PubMed  Article  CAS  Google Scholar 

  30. 30.

    Raynor DK, Booth TG, Blenkinsopp A. Effects of computer generated reminder charts on patients’ compliance with drug regimens. BMJ. 1993;306:1158–61.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  31. 31.

    Santos Dde O, Martins MC, Cipriano SL, Pinto RM, Cukier A, Stelmach R. Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications. Jornal brasileiro de pneumologia. 2010:14–22.

  32. 32.

    Begley S, Livingstone C, Hodges N, Williamson V. Impact of domiciliary pharmacy visits on medication management in an elderly population. Int J Pharm Pract. 1997;5:111–21.

    Article  Google Scholar 

  33. 33.

    Abdelhamid E, Awad A, Gismallah A. Evaluation of a hospital pharmacy-based pharmaceutical care services for asthma patients. Pharm Pract (Granada). 2008:25–32.

  34. 34.

    Adepu R, Rasheed A, Nagavi B. Effect of patient counseling on quality of life in type-2 diabetes mellitus patients in two selected South Indian community pharmacies: A study. Indian J Pharm Sci. 2007:519–24.

  35. 35.

    Adler DA. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry. 2004:11.

  36. 36.

    Bock BC, Hudmon KS, Christian J, Graham AL, Bock FR. A tailored intervention to support pharmacy-based counseling for smoking cessation. Nicotine Tob Res. 2010;12:217–25.

    PubMed  Article  PubMed Central  Google Scholar 

  37. 37.

    Carter BL, Bergus GR, Dawson JD, Farris KB, Doucette WR, Chrischilles EA, Hartz AJ. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich). 2008;10:260–71.

    Article  Google Scholar 

  38. 38.

    Baker D, Roberts DE, Newcombe RG, Fox KA. Evaluation of drug information for cardiology patients. Br J Clin Pharmacol. 1991:525–31.

  39. 39.

    Bolas H, Brookes K, Scott M, McElnay J. Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland. Pharm World Sci. 2004:114–120.

  40. 40.

    Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21:1196–203.

    PubMed  Article  CAS  Google Scholar 

  41. 41.

    Vuong T, Marriott JL, Kong DCM, Siderov J. Implementation of a community liaison pharmacy service: a randomised controlled trial. Int J Pharm Pract. 2008;16:127–35.

    Article  Google Scholar 

  42. 42.

    Clifford S, Barber N, Elliott R, Hartley E, Horne R. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci. 2006;28:165–70.

    PubMed  Article  Google Scholar 

  43. 43.

    Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield AJ, Donnan PT. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tob Control. 1998;7:253–61.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  44. 44.

    Gauthier I, Malone M, Lesar TS, Aronovitch S. Comparison of programs for preventing drug-nutrient interactions in hospitalized patients. Am J Health Syst Pharm. 1997:405–411.

  45. 45.

    Al-Eidan FA, McElnay JC, Scott MG, McConnell JB. Management of helicobacter pylori eradication - The influence of structured counseling and follow-up. Br J Clin Pharmacol. 2002;53:163–71.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  46. 46.

    Berger BA, Liang H, Hudmon KS. Evaluation of software-based telephone counseling to enhance medication persistency among patients with multiple sclerosis. Am J Health Syst Pharm. 2005;45:466–72.

    Google Scholar 

  47. 47.

    Faulkner MA. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized controlled trial. Pharmacotherapy. 2000;20:410–6.

    PubMed  Article  CAS  Google Scholar 

  48. 48.

    Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients’ clinical condition in heart failure?. Br J Clin Pract. 1995:173–176.

  49. 49.

    Hammad EA, Yasein N, Tahaineh L, Albsoul-Younes AM. A randomized controlled trial to assess pharmacist- physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan. J Manag Care Pharm. 2011;17:295–303.

    PubMed  Google Scholar 

  50. 50.

    Hoffmann W, Herzog B, Mühlig S, Kayser H, Fabian R, Thomsen M, Cramer M, Fiss T, Gresselmeyer D, Janhsen K. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention. Ann Pharmacother. 2008;42:1804–13.

    PubMed  Article  Google Scholar 

  51. 51.

    Koehler BE, Richter KM, Youngblood L, Cohen BA, Prengler ID, Cheng D, Masica AL. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009;4:211–8.

    PubMed  Article  Google Scholar 

  52. 52.

    Ma Y, Ockene IS, Rosal MC, Merriam PA, Ockene JK, Gandhi PJ. Randomized trial of a pharmacist-delivered intervention for improving lipid-lowering medication adherence among patients with coronary heart disease. Cholesterol 2010. 2010.

  53. 53.

    Evans CD, Eurich T, Taylor JG, Blackburn DF. The collaborative cardiovascular risk reduction in primary care (CCARP) study. Pharmacotherapy. 2010;30:766–75.

    PubMed  Article  CAS  Google Scholar 

  54. 54.

    Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, Kachalia A, Horng M, Roy CL, McKean SC, Bates DW. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Int Med. 2006;166:565–71.

    Article  Google Scholar 

  55. 55.

    Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, Chrystyn H. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital. Br J Clin Pharmacol. 1997;44:163–5.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  56. 56.

    Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc. 1998:174–180.

  57. 57.

    Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc. 1996:443–451.

  58. 58.

    Villeneuve J, Genest J, Blais L, Vanier MC, Lamarre D, Fredette M, Lussier MT, Perreault S, Hudon E, Berbiche D, Lalonde L. A cluster randomized controlled trial to evaluate an ambulatory primary care management program for patients with dyslipidemia: the team study. CMAJ. 2010;182(5):447–55.

    PubMed  Article  PubMed Central  Google Scholar 

  59. 59.

    Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect of information leaflets and counseling on antidepressant adherence: open randomised controlled trial in a psychiatric hospital in Kuwait. Int J Pharm Prac. 2005;13:123.

    Article  Google Scholar 

  60. 60.

    Scullin C, Scott MG, Hogg A, McElnay JC. An innovative approach to integrated medicines management. J Eval Clin Pract. 2007:781–788.

  61. 61.

    Sushmita S, Aarati K, Bharat P, Roshani S, Sunil S, Kalpana P, Kumar UD. Knowledge, attitude and practice outcomes: an effect of pharmacist provided counseling in hypertensive patients in a tertiary care teaching hospital in Western Nepal. Int J Pharm Sci. 2010;2:583–8.

    Google Scholar 

  62. 62.

    Vial RJ, Jones TE, Ruffin RE, Gilbert AL. Smoking cessation program using nicotine patches linking hospital to the community. J Pharm Pract Res. 2002;32:57–62.

    Google Scholar 

  63. 63.

    Mai A, Aslani P. Impact of Vietnamese written and verbal medicine information on Vietnamese-speaking Australians’ knowledge and satisfaction. Br J Clin Pharmacol. 2007;64:527–35.

    PubMed  Article  PubMed Central  Google Scholar 

  64. 64.

    Wang KY, Chian CF, Lai HR, Tarn YH, Wu CP. Clinical pharmacist counseling improves outcomes for Taiwanese asthma patients. Pharm World Sci. 2010;32:721–9.

    PubMed  Article  Google Scholar 

  65. 65.

    Wu JY, Leung WY, Chang S, Lee B, Zee B, Tong PC, Chan JC. Effectiveness of telephone counseling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ. 2006; 9;333(7567):522.

  66. 66.

    Barnett CW, Nykamp D, Ellington AM. Patient-guided counseling in the community pharmacy setting. J Am Pharm Assoc (Wash). 2000:765–772.

  67. 67.

    Bynum A, Hopkins D, Thomas A, Copeland N, Irwin C. The effect of telepharmacy counseling on metered-dose inhaler technique among adolescents with asthma in rural Arkansas. Telemed J E Health. 2001:207–217.

  68. 68.

    Kassam R, Farris KB, Burback L, Volume CI, Cox CE, Cave A. Pharmaceutical care research and education project: pharmacists’ interventions 2001. J Am Pharm Assoc (Wash). 2001;41(3):401–10.

    CAS  Google Scholar 

  69. 69.

    Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002;22:1533–40.

    PubMed  Article  Google Scholar 

  70. 70.

    Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, Seshadri R, Caffrey H, Roesner JF, Smith F, Newell AJ, Collins JC, McDonald CJ, Tierney WM. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. J Amer Med Assoc. 2002;288:1594–602.

    Article  Google Scholar 

  71. 71.

    Suppapitiporn S, Chindavijak B, Onsanit S. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. J Med Assoc Thai. 2005;88:S134–41.

    PubMed  Google Scholar 

  72. 72.

    Eussen SR, van der Elst ME, Klungel OH, Rompelberg CJ, Garssen J, Oosterveld MH, de Boer A, de Gier JJ, Bouvy ML. A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial. Ann Pharmacother. 2010;44:1905–13.

    PubMed  Article  Google Scholar 

  73. 73.

    Tobari H, Arimoto T, Shimojo N, Yuhara K, Noda H, Yamagishi K, Iso H. Physician-pharmacist cooperation program for blood pressure control in patients with hypertension: a randomized-controlled trial. Am J Hypertens. 2010;23:1144–52.

    PubMed  Article  CAS  Google Scholar 

  74. 74.

    Costello MJ, Sproule B, Victor JC, Leatherdale ST, Zawertailo L, Selby P. Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers. Cancer Causes Control. 2011:167–180.

  75. 75.

    Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33:132–40.

    PubMed  Article  PubMed Central  Google Scholar 

  76. 76.

    Kraemer DF, Kradjan WA, Bianco TM, Low JA. A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: the EMPOWER study. J Pharm Pract. 2012;25(2):169–79.

    PubMed  Article  Google Scholar 

  77. 77.

    Malathy R, Narmadha MP, Ramesh S, Alvin JM, Young BNDJ. Effect of a diabetes counseling programme on knowledge, attitude and practice among diabetic patients in Erode district of South India. Pharmacists. 2011;3(1):65–72.

    Article  CAS  Google Scholar 

  78. 78.

    Lai PS, Chua SS, Chew YY, Chan SP. Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women. J Clin Pharm Ther. 2011;36(5):557–67.

    PubMed  Article  CAS  Google Scholar 

  79. 79.

    Ramanath KV, Santosh YL. Impact of clinical pharmacist provided patient education on QoL outcome in type II diabetes mellitus in rural population. Asian J Pharm Clin Res. 2011;4(4):15–20.

    Google Scholar 

  80. 80.

    Van de Steeg-van Gompel CH, Wensing M, de Smet PA. Implementation of patient education at first and second dispensing of statins in Dutch community pharmacies: the sequel of a cluster randomized trial. BMC Health Serv Res. 2011;16(11):313.

    Article  Google Scholar 

  81. 81.

    Eussen SR, Bouvy ML, Rompelberg CJ, van der Elst ME, Garssen J, Oosterveld MH, de Boer A, de Gier JJ, van Kranen HJ, Klungel OH. Influence of the use of functional foods enriched with phytosterols/-stanols on adherence to statin therapy. Pharmacoepidemiol Drug Saf. 2011;20(8):830–7.

    PubMed  Article  CAS  Google Scholar 

  82. 82.

    Moideen MM, Varghese R, Ramakrishnan P, Dhanapal CK. Patient education for overweight and obese patients on weight reduction in an urban community pharmacy and its outcome. Res J Pharm Biol Chem Sci. 2011;2(4):393.

    Google Scholar 

  83. 83.

    Chan CW, Siu SC, Wong CK, Lee VW. A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther. 2012;17(1):57–64.

    PubMed  Article  Google Scholar 

  84. 84.

    Zhang C, Zhang L, Huang L, Luo R, Wen J. Clinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trial. PLoS One. 2012; 7(1).

  85. 85.

    Shah M, Norwood CA, Farias S, Ibrahim S, Chong PH, Fogelfeld L. Diabetes transitional care from inpatient to outpatient setting: pharmacist discharge counseling. J Pharm Pract. 2013;26(2):120–4.

    PubMed  Article  Google Scholar 

  86. 86.

    Fletcher J, Hogg W, Farrell B, Woodend K, Dahrouge S, Lemelin J, Dalziel W. Effect of nurse practitioner and pharmacist counseling on inappropriate medication use in family practice. Can Fam Physician. 2012;58(8):862–8.

    PubMed  PubMed Central  Google Scholar 

  87. 87.

    Zhao PX, Wang C, Qin L, Yuan M, Xiao Q, Guo YH, Wen AD. Effect of clinical pharmacist’s pharmaceutical care intervention to control hypertensive outpatients in China. Afr J Pharm Pharmacol. 2012;6(1):48–56.

    Article  Google Scholar 

  88. 88.

    Amariles P, Sabater-Hernández D, García-Jiménez E, Rodríguez-Chamorro MÁ, Prats-Más R, Marín-Magán F, Galán-Ceballos JA, Jiménez-Martín J, Faus MJ. Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: eMDADER-CV randomized controlled trial. J Manag Care Pharm. 2012;18(4):311–23.

    PubMed  Google Scholar 

  89. 89.

    Patwardhan PD, Chewning BA. Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies. J Am Pharm Assoc. 2012;52(4):507–14.

    Article  Google Scholar 

  90. 90.

    Nishita C, Cardazone G, Uehara DL, Tom T. Empowered diabetes management: life coaching and pharmacist counseling for employed adults with diabetes. Health Educ Behav. 2013;40(5):581–91.

    PubMed  Article  Google Scholar 

  91. 91.

    Willoch K, Blix HS, Pedersen-Bjergaard AM, Eek AK, Reikvam A. Handling drug-related problems in rehabilitation patients: a randomized study. Int J Clin Pharm. 2012;34(2):382–8.

    PubMed  Article  Google Scholar 

  92. 92.

    Ali M, Schifano F, Robinson P, Phillips G, Doherty L, Melnick P, Laming L, Sinclair A, Dhillon S. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabet Med. 2012;29(9).

  93. 93.

    Ulayar AS, Lopez SG, Llobet NP, Sancho AM, Bernadàs LC, Mendez RM. Pharmaceutical intervention upon hospital discharge to strengthen understanding and adherence to pharmacological treatment. Farmacia Hospitalaria. 2012; 36(03).

  94. 94.

    Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen LaPointe NM. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am Heart J. 2012;163(4):657–65.

    PubMed  Article  Google Scholar 

  95. 95.

    Shanmugam S, Varughese J, Nair MAS, Balasubramanian R, Velu S, Bhojan C, Devarajan V, Sabzghabaee AM. Pharmaceutical care for asthma patients: a developing country’s experience. J Res Pharm Pract. 2012;1(2):66–71.

    PubMed  Article  PubMed Central  Google Scholar 

  96. 96.

    Lai PS, Chua SS, Chan SP. Pharmaceutical care issues encountered by post-menopausal osteoporotic women prescribed bisphosphonates. J Clin Pharm Ther. 2012;37(5):536–43.

    PubMed  Article  CAS  Google Scholar 

  97. 97.

    Chua SS, Kok LC, Yusof FA, Tang GH, Lee SW, Efendie B, Paraidathathu T. Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings. BMC Health Serv Res. 2012;12:388.

  98. 98.

    Jacobs M, Sherry PS, Taylor LM, Amato M, Tataronis GR, Cushing G. Pharmacist assisted medication program enhancing the regulation of diabetes (PAMPERED) study. J Am Pharm Assoc. 2012;52(5):613–21.

    Article  Google Scholar 

  99. 99.

    Alsabbagh MW, Lemstra M, Eurich D, Wilson TW, Robertson P, Blackburn DF. Pharmacist intervention in cardiac rehabilitation: a randomized controlled trial. J Cardiopulm Rehabil Prev. 2012;32(6):394–9.

    PubMed  Article  Google Scholar 

  100. 100.

    Mohammed SS, Alhas JJK, Siraj S. Study on the impact of patient counseling on the quality of life and pulmonary function of asthmatic patient. Int J Pharm Pharm Sci. 2012;4(5):300–4.

    Google Scholar 

  101. 101.

    Zillich AJ, Corelli RL, Zbikowski SM, Magnusson B, Fenlon CM, Prokhorov AV, Moor C, Hudmon KS. A randomized trial evaluating two approaches for promoting pharmacy-based referrals to the tobacco quitline: methods and baseline findings. Res Social Adm Pharm. 2013;9(1):27–36.

    PubMed  Article  PubMed Central  Google Scholar 

  102. 102.

    Wang Y, Huang H, Zeng Y, Wu J, Wang R, Ren B, Xu F. Pharmacist-led medication education in cancer pain control: a multicentre randomized controlled study in Guangzhou. China J Int Med Res. 2013;41(5):1462–72.

    Article  Google Scholar 

  103. 103.

    Lakshmi R, James E, Kirthivasan R. Study on impact of clinical pharmacist’s interventions in the optimal use of oral anticoagulants in stroke patients. Indian J Pharm Sci. 2013;75(1):53–9.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  104. 104.

    Ramanath KV, Venkappa KR. Study the impact of clinical pharmacist provided patient counseling on hypertension management in rural Indian population. Archives Pharm Pract. 2013;4(1):28–34.

    Article  Google Scholar 

  105. 105.

    Phimarn W, Pianchana P, Limpikanchakovit P, Suranart K, Supapanichsakul S, Narkgoen A, Saramunee K. Thai community pharmacist involvement in weight management in primary care to improve patient’s outcomes. Int J Clin Pharm. 2013;35(6):1208–17.

    PubMed  Article  Google Scholar 

  106. 106.

    Correr CJ, Melchiors AC, de Souza TT, Rotta I, Salgado TM, Fernandez-Llimos F. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project. Ann Pharmacother. 2013;47(7–8):946–52.

    PubMed  Article  Google Scholar 

Download references

Funding

This work was supported by CAPES/CNPq (Culture and Education Ministry/Brazilian Government).

Conflicts of interest

The authors declare that they do not have any conflicts of interest with regard to this study.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Lucas Miyake Okumura.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 12 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Okumura, L.M., Rotta, I. & Correr, C.J. Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review. Int J Clin Pharm 36, 882–891 (2014). https://doi.org/10.1007/s11096-014-9982-1

Download citation

Keywords

  • Medication adherence
  • Patient counseling
  • Patient medication knowledge
  • Pharmacist
  • Quality of health care